SG11201502778TA - Method of prognosis and stratification of ovarian cancer - Google Patents

Method of prognosis and stratification of ovarian cancer

Info

Publication number
SG11201502778TA
SG11201502778TA SG11201502778TA SG11201502778TA SG11201502778TA SG 11201502778T A SG11201502778T A SG 11201502778TA SG 11201502778T A SG11201502778T A SG 11201502778TA SG 11201502778T A SG11201502778T A SG 11201502778TA SG 11201502778T A SG11201502778T A SG 11201502778TA
Authority
SG
Singapore
Prior art keywords
stratification
prognosis
ovarian cancer
ovarian
cancer
Prior art date
Application number
SG11201502778TA
Inventor
Vladimir Andreevich Kuznetsov
Zhiqun Tang
Ghim Siong Ow
Anna Vladimirovna Ivshina
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG11201502778TA priority Critical patent/SG11201502778TA/en
Publication of SG11201502778TA publication Critical patent/SG11201502778TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111General methods applicable to biologically active non-coding nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • C12N2310/141MicroRNAs, miRNAs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/10Applications; Uses in screening processes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
SG11201502778TA 2012-10-12 2013-10-11 Method of prognosis and stratification of ovarian cancer SG11201502778TA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG11201502778TA SG11201502778TA (en) 2012-10-12 2013-10-11 Method of prognosis and stratification of ovarian cancer

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG2012076915 2012-10-12
SG11201502778TA SG11201502778TA (en) 2012-10-12 2013-10-11 Method of prognosis and stratification of ovarian cancer
PCT/SG2013/000436 WO2014058394A1 (en) 2012-10-12 2013-10-11 Method of prognosis and stratification of ovarian cancer

Publications (1)

Publication Number Publication Date
SG11201502778TA true SG11201502778TA (en) 2015-05-28

Family

ID=54141527

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201703022SA SG10201703022SA (en) 2012-10-12 2013-10-11 Method of prognosis and stratification of ovarian cancer
SG11201502778TA SG11201502778TA (en) 2012-10-12 2013-10-11 Method of prognosis and stratification of ovarian cancer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201703022SA SG10201703022SA (en) 2012-10-12 2013-10-11 Method of prognosis and stratification of ovarian cancer

Country Status (5)

Country Link
US (1) US20150267259A1 (en)
EP (1) EP2906724A4 (en)
CN (1) CN104854247A (en)
SG (2) SG10201703022SA (en)
WO (1) WO2014058394A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9953417B2 (en) * 2013-10-04 2018-04-24 The University Of Manchester Biomarker method
CN108091398B (en) * 2016-11-21 2022-03-04 医渡云(北京)技术有限公司 Patient grouping method and device
CN107050469B (en) * 2017-01-18 2019-07-30 中国科学院昆明动物研究所 The purposes of people's NCAPH gene
CN108229099B (en) * 2017-12-29 2021-01-05 北京科迅生物技术有限公司 Data processing method, data processing device, storage medium and processor
CN108470111B (en) * 2018-05-09 2022-01-18 中国科学院昆明动物研究所 Stomach cancer personalized prognosis evaluation method based on polygene expression profile
CN108647493B (en) * 2018-05-09 2022-01-18 中国科学院昆明动物研究所 Individualized prognosis evaluation method for renal clear cell carcinoma
WO2019226514A2 (en) * 2018-05-21 2019-11-28 Nanostring Technologies, Inc. Molecular gene signatures and methods of using same
US11462325B2 (en) * 2018-09-29 2022-10-04 Roche Molecular Systems, Inc. Multimodal machine learning based clinical predictor
GB201902653D0 (en) * 2019-02-27 2019-04-10 Univ Oxford Innovation Ltd High-grade serous ovarian carcinoma (HGSOC)
CN110452982A (en) * 2019-05-08 2019-11-15 中山大学孙逸仙纪念医院 Breast cancer circulating tumor cell miRNA and EMT markers in detecting kit and its application
CN110551819B (en) * 2019-08-23 2023-05-16 伯克利南京医学研究有限责任公司 Application of ovarian cancer prognosis related genes
CN111705060B (en) * 2020-06-29 2023-07-28 北京大学深圳医院 shRNA of NCAPD2 gene and application thereof
CN111781364B (en) * 2020-08-25 2023-07-21 北京信诺卫康科技有限公司 Wnt7a and HE4 combined as early ovarian cancer biomarker and kit
CN112289450B (en) * 2020-12-25 2021-05-18 浙江高美生物科技有限公司 Prediction system for prognosis survival period of intrahepatic cholangiocellular carcinoma patient
CN113774135B (en) * 2021-09-17 2024-03-08 广东省人民医院 Group of markers for predicting prognosis of high-grade serous ovarian cancer and application thereof
CN114381529B (en) * 2022-03-16 2022-06-10 上海晟燃生物科技有限公司 Application of ACTR10 and CA125 combination in ovarian cancer detection and kit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008095096A2 (en) * 2007-01-31 2008-08-07 Immune Disease Institute Let-7 microrna and mimetics thereof as therapeutics for cancer
US8030060B2 (en) * 2007-03-22 2011-10-04 West Virginia University Gene signature for diagnosis and prognosis of breast cancer and ovarian cancer
WO2010083312A2 (en) * 2009-01-14 2010-07-22 The Trustees Of The University Of Pennsylvania Micro-rna biomarker in cancer
US9953129B2 (en) * 2011-09-23 2018-04-24 Agency For Science, Technology And Research Patient stratification and determining clinical outcome for cancer patients

Also Published As

Publication number Publication date
WO2014058394A1 (en) 2014-04-17
EP2906724A1 (en) 2015-08-19
US20150267259A1 (en) 2015-09-24
EP2906724A4 (en) 2016-12-14
SG10201703022SA (en) 2017-06-29
CN104854247A (en) 2015-08-19

Similar Documents

Publication Publication Date Title
SG10201703022SA (en) Method of prognosis and stratification of ovarian cancer
IL276488A (en) Method of predicting breast cancer prognosis
HK1206431A1 (en) Method for the prognosis and treatment of cancer metastasis
HK1219763A1 (en) Compositions and methods for cancer prognosis
HK1212256A1 (en) Anti-mcam antibodies and associated methods of use -mcam
IL237791B (en) Method of treating cancer
HK1204302A1 (en) Compositions and methods for cancer immunotherapy
EP2922861A4 (en) Biomarker compositions and methods
PL2908823T3 (en) Methods of treating cancer
SG11201503893RA (en) Method of treating cancer
HK1197273A1 (en) Methods and materials related to ovarian cancer
HK1206414A1 (en) Biomarkers for gastric cancer and uses thereof
HK1259001A1 (en) Methods of prognosis and diagnosis of cancer
HK1215193A1 (en) Methods of treating ovarian cancer with dll4 antagonists dll4
HK1205558A1 (en) Methods and biomarkers for detection and prognosis of cervical cancer
EP2895206A4 (en) Method of treating cancer
GB2510539B (en) Biomarkers of cancer
HK1200502A1 (en) Method for determining prognosis of prostate cancer in a subject
EP2812694A4 (en) Assays and methods for the diagnosis of ovarian cancer
EP2709730A4 (en) Treatment and prognosis of cancer
IL239426A0 (en) Biomarker methods and compositions
EP2916200A4 (en) Semi-compact keyboard and method therefor
ZA201503833B (en) Method of hemoglobin-f determination
GB201222952D0 (en) Treatent of cancer